Symposia & Webinars
What is the key evidence supporting LDL-C control at lower targets, with earlier intervention for better outcomes in the long-term?
Dr. Pérez de Isla speaks about LDL-C lowering focused on 3 main aspects:
Get it low:
- Reduce as much as possible the level of LDL-C in order to achieve the greater reduction of number of vascular events.
Get it soon:
- Check lipid level in order to achieve the goal set by guidelines. Time is very important.
- Single pill combinations provide a strategic approach that supports the early reaching of lipid goals without increasing pill burden and complexity of treatment, favouring adherence (vs two pills).
Get it forever:
- If there are no adverse events or any other conditions, keep long term treatment to improve the patients’ health.
Final recommendation: ”Let’s treat atherosclerosis not just stenosis”.
This video is part of the session “Choosing the best treatment approach to dyslipidemia: monotherapy vs combination therapy” held virtually at ESC congress 2020 on Monday August 31st, 2020, with co-chairs A. Zambon and L. Perez de Isla.
View also the other parts of the congress session: